AVITA Medical, Inc. (RCEL) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts RCEL Hot Sheet
Join SI Premium – FREE
AVITA Medical, Inc. (NASDAQ: RCEL) reported Q3 EPS of ($0.22), $0.11 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $9.09 million versus the consensus estimate of $7.47 million.
For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASM International posts Q3 net income of €308.1m, raises 2027 revenue target
- Camden National (CAC) Reports In-Line Q3 EPS
- Euronet Worldwide (EEFT) Misses Q3 EPS by 14c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
